Your browser doesn't support javascript.
loading
Bismuth Nanoparticles Increase Effectiveness of Proton Therapy of Ehrlich Carcinoma.
Filimonova, M V; Soldatova, O V; Shitova, A A; Filimonov, A S; Rybachuk, V A; Kosachenko, A O; Nikolaev, K A; Demyashkin, G A; Popov, A A; Zelepukin, I V; Kabashin, A V; Deev, S M; Kaprin, A D; Shegay, P V; Ivanov, S A; Zavestovskaya, I N; Koryakin, S N.
Afiliação
  • Filimonova MV; A. Tsyb Medical Radiological Research Center - Branch of the National Medical Research Radiological Centre, Ministry of Health of the Russian Federation, Obninsk, Russia. mari_fil@mail.ru.
  • Soldatova OV; Obninsk Institute for Nuclear Power Engineering, National Research Nuclear University MEPhI, Obninsk, Russia. mari_fil@mail.ru.
  • Shitova AA; A. Tsyb Medical Radiological Research Center - Branch of the National Medical Research Radiological Centre, Ministry of Health of the Russian Federation, Obninsk, Russia.
  • Filimonov AS; A. Tsyb Medical Radiological Research Center - Branch of the National Medical Research Radiological Centre, Ministry of Health of the Russian Federation, Obninsk, Russia.
  • Rybachuk VA; A. Tsyb Medical Radiological Research Center - Branch of the National Medical Research Radiological Centre, Ministry of Health of the Russian Federation, Obninsk, Russia.
  • Kosachenko AO; A. Tsyb Medical Radiological Research Center - Branch of the National Medical Research Radiological Centre, Ministry of Health of the Russian Federation, Obninsk, Russia.
  • Nikolaev KA; A. Tsyb Medical Radiological Research Center - Branch of the National Medical Research Radiological Centre, Ministry of Health of the Russian Federation, Obninsk, Russia.
  • Demyashkin GA; A. Tsyb Medical Radiological Research Center - Branch of the National Medical Research Radiological Centre, Ministry of Health of the Russian Federation, Obninsk, Russia.
  • Popov AA; A. Tsyb Medical Radiological Research Center - Branch of the National Medical Research Radiological Centre, Ministry of Health of the Russian Federation, Obninsk, Russia.
  • Zelepukin IV; National Research Nuclear University MEPhI, Moscow, Russia.
  • Kabashin AV; Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.
  • Deev SM; Aix-Marseille University, Marseille, France.
  • Kaprin AD; Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.
  • Shegay PV; National Medical Research Radiological Centre, Ministry of Health of the Russian Federation, Moscow, Russia.
  • Ivanov SA; Patrice Lumumba Peoples' Friendship University of Russia, (RUDN University), Moscow, Russia.
  • Zavestovskaya IN; A. Tsyb Medical Radiological Research Center - Branch of the National Medical Research Radiological Centre, Ministry of Health of the Russian Federation, Obninsk, Russia.
  • Koryakin SN; National Medical Research Radiological Centre, Ministry of Health of the Russian Federation, Moscow, Russia.
Bull Exp Biol Med ; 176(5): 626-630, 2024 Mar.
Article em En | MEDLINE | ID: mdl-38730109
ABSTRACT
We studied the antitumor activity of the combined use of local proton irradiation in two modes (10 and 31 Gy) with preliminary intra-tumoral injection of two types of bismuth nanoparticles differing in surface coating coated with the amphiphilic molecule Pluronic-F127 or Silane-PEG (5 kDa)-COOH polymer. Nanoparticles were used in doses of 0.75 and 1.5 mg/mouse. In two independent series on experimental tumor model (solid Ehrlich carcinoma), bismuth nanoparticles of both modifications injected directly into the tumor enhanced the antitumor effects of proton therapy. Moreover, the radiosensitizing effect of bismuth nanoparticles administered via this route increased with the increasing the doses of nanoparticles and the doses of radiation exposure. In our opinion, these promising data obtained for the first time extend the possibilities of treating malignant neoplasms.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Bismuto / Carcinoma de Ehrlich / Poloxâmero / Terapia com Prótons Limite: Animals Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Bismuto / Carcinoma de Ehrlich / Poloxâmero / Terapia com Prótons Limite: Animals Idioma: En Ano de publicação: 2024 Tipo de documento: Article